In order to lay out the 3D printing absorbable orthopedic implant product production line and bioabsorbable orthopedic material R&D base in advance, the company's management finally selected Weili Medical Science Innovation Park in Suzhou Industrial Park as the new production research and development base. On December 22, 2023, Chen Chongguang, chairman of T-Bright Biotechnology, signed a site lease contract with Xu Shoujuan, head of Weili Medical Science and Innovation Park.

Suzhou Industrial Park has been ranked first in the comprehensive evaluation of the national economic development Zone of the Ministry of Commerce for many consecutive years, and ranks among the world-class high-tech parks built by the Ministry of Science and Technology. The competitiveness of the biomedical industry of Suzhou Industrial Park ranks first in the national high-tech zones.

After entering Suzhou Industrial Park Weili Medical Science and Technology Innovation Park, T-Bright Biotechnology will fully enjoy the advantages of Suzhou Industrial Park science and technology talent policy and industrial supporting, stand on a higher platform, inject greater impetus, and strive to make new contributions to the development of China's biomedical device industry.